Seeking information and discussion regarding evidence-based recommendations for genetic testing in the clinical management of individuals with Cystic Fibrosis Transmembrane Conductance Regulator-related Metabolic Syndrome (CRMS) or Cystic Fibrosis Screen-Positive, Inconclusive Diagnosis (CFSPID).